123 related articles for article (PubMed ID: 1614815)
1. Altered cell volume regulation in ras oncogene expressing NIH fibroblasts.
Lang F; Ritter M; Wöll E; Weiss H; Häussinger D; Hoflacher J; Maly K; Grunicke H
Pflugers Arch; 1992 Apr; 420(5-6):424-7. PubMed ID: 1614815
[TBL] [Abstract][Full Text] [Related]
2. Cytoskeletal reorganization in NIH 3T3 fibroblasts expressing the ras oncogene.
Dartsch PC; Ritter M; Häussinger D; Lang F
Eur J Cell Biol; 1994 Apr; 63(2):316-25. PubMed ID: 8082656
[TBL] [Abstract][Full Text] [Related]
3. Effects of bradykinin on cell volume and intracellular pH in NIH 3T3 fibroblasts expressing the ras oncogene.
Ritter M; Wöll E; Häussinger D; Lang F
FEBS Lett; 1992 Aug; 307(3):367-70. PubMed ID: 1322838
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin inhibits malignant transformation following expression of the Ha-ras oncogene in NIH 3T3 fibroblasts.
Fürst J; Haller T; Chwatal S; Wöll E; Dartsch PC; Gschwentner M; Dienstl A; Zwierzina H; Lang F; Paulmichl M; Ritter M
Cell Physiol Biochem; 2002; 12(1):19-30. PubMed ID: 11914545
[TBL] [Abstract][Full Text] [Related]
5. Effects of HOE 694--a novel inhibitor of Na+/H+ exchange--on NIH 3T3 fibroblasts expressing the RAS oncogene.
Wöll E; Ritter M; Offner F; Lang HJ; Schölkens B; Hüssinger D; Lang F
Eur J Pharmacol; 1993 Aug; 246(3):269-73. PubMed ID: 8223949
[TBL] [Abstract][Full Text] [Related]
6. Effects of bradykinin on NIH 3T3 fibroblasts pretreated with lithium. Mimicking events of Ha-ras oncogene expression.
Ritter M; Dartsch P; Waldegger S; Haller T; Zwierzina H; Lang HJ; Lang F
Biochim Biophys Acta; 1997 Aug; 1358(1):23-30. PubMed ID: 9296517
[TBL] [Abstract][Full Text] [Related]
7. Activation of Na+/H(+)-exchanger by transforming Ha-ras requires stimulated cellular calcium influx and is associated with rearrangement of the actin cytoskeleton.
Ritter M; Wöll E; Haller T; Dartsch PC; Zwierzina H; Lang F
Eur J Cell Biol; 1997 Mar; 72(3):222-8. PubMed ID: 9084984
[TBL] [Abstract][Full Text] [Related]
8. Cell membrane potential oscillations induced by kinins in fibroblasts expressing the Ha-ras oncogene.
Lang F; Wöll E; Waldegger S; Friedrich F; Ritter M; Pinggera G; Kloiber K; Bichler I; Heitzenberger H; Maly K
Agents Actions Suppl; 1992; 38 ( Pt 2)():73-80. PubMed ID: 1462847
[TBL] [Abstract][Full Text] [Related]
9. Effects of inhibitors and ion substitutions on oscillations of cell membrane potential in cells expressing the RAS oncogene.
Lang F; Waldegger S; Woell E; Ritter M; Maly K; Grunicke H
Pflugers Arch; 1992 Aug; 421(5):416-24. PubMed ID: 1461714
[TBL] [Abstract][Full Text] [Related]
10. Effects of calcium channel blockers on NIH 3T3 fibroblasts expressing the Ha-ras oncogene.
Dartsch PC; Ritter M; Gschwentner M; Lang HJ; Lang F
Eur J Cell Biol; 1995 Aug; 67(4):372-8. PubMed ID: 8521877
[TBL] [Abstract][Full Text] [Related]
11. Cell shrinkage stimulates bradykinin-induced cell membrane potential oscillations in NIH 3T3 fibroblasts expressing the ras-oncogene.
Ritter M; Wöll E; Waldegger S; Häussinger D; Lang HJ; Scholz W; Schölkens B; Lang F
Pflugers Arch; 1993 May; 423(3-4):221-4. PubMed ID: 8321624
[TBL] [Abstract][Full Text] [Related]
12. Effect of calcium channel antagonists on cell membrane potential oscillations and proliferation of cells expressing the ras oncogene.
Wöll E; Weiss H; Waldegger S; Lang F
Eur J Pharmacol; 1992 Feb; 212(1):105-7. PubMed ID: 1555632
[TBL] [Abstract][Full Text] [Related]
13. The role of calcium in cell shrinkage and intracellular alkalinization by bradykinin in Ha-ras oncogene expressing cells.
Wöll E; Ritter M; Scholz W; Häussinger D; Lang F
FEBS Lett; 1993 May; 322(3):261-5. PubMed ID: 7683612
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of intracellular calcium oscillations in fibroblasts expressing the ras oncogene.
Wöll E; Waldegger S; Lang F; Maly K; Grunicke H
Pflugers Arch; 1992 Feb; 420(2):208-12. PubMed ID: 1620579
[TBL] [Abstract][Full Text] [Related]
15. Cell volume in the regulation of cell proliferation and apoptotic cell death.
Lang F; Ritter M; Gamper N; Huber S; Fillon S; Tanneur V; Lepple-Wienhues A; Szabo I; Gulbins E
Cell Physiol Biochem; 2000; 10(5-6):417-28. PubMed ID: 11125224
[TBL] [Abstract][Full Text] [Related]
16. Regulation of vascular endothelial cell volume by Na-K-2Cl cotransport.
O'Neill WC; Klein JD
Am J Physiol; 1992 Feb; 262(2 Pt 1):C436-44. PubMed ID: 1539632
[TBL] [Abstract][Full Text] [Related]
17. Transformation of mouse fibroblasts with the oncogenes H-ras OR trk is associated with pronounced changes in drug sensitivity and metabolism.
Peters GJ; Wets M; Keepers YP; Oskam R; van Ark-Otte J; Noordhuis P; Smid K; Pinedo HM
Int J Cancer; 1993 May; 54(3):450-5. PubMed ID: 8509220
[TBL] [Abstract][Full Text] [Related]
18. Modification of Cellular Ion Transport by the Ha-ras Oncogene: Steps towards Malignant Transformation.
Ritter M; Wöll E
Cell Physiol Biochem; 1996; 6(5):245-270. PubMed ID: 32690257
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Na+-H+ exchange in normal NIH-3T3 cells and in NIH-3T3 cells expressing the ras oncogene.
Owen NE; Knapik J; Strebel F; Tarpley WG; Gorman RR
Am J Physiol; 1989 Apr; 256(4 Pt 1):C756-63. PubMed ID: 2539724
[TBL] [Abstract][Full Text] [Related]
20. Role of Na-K-Cl cotransport in vascular endothelial cell volume regulation.
O'Donnell ME
Am J Physiol; 1993 May; 264(5 Pt 1):C1316-26. PubMed ID: 8498488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
